This is supported by both our and other previous reports showing that CSCs reduced the post-MI fibrotic process and reduced infract size [21, 30, 31, 36], suggesting that the anti-remodeling effect of CSCs in cell-engrafted MI hearts is also mediated through a Oct3/4-dependent cellular mechanism. The gene discussed is POU5F1; the disease is myocardial infarction.